An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
The addition of botulinum toxin type A to an upper limb therapy programme for post stroke spasticity did not improve active upper limb function, but was useful for improving basic functional tasks (e.g. hand hygiene) and pain. However, treatment was not cost-effective at willingness-to-pay levels of NHS decision makers.
1 Institute for Ageing and Health (Stroke Research Group), Newcastle University, Newcastle upon Tyne, UK
2 Northumbria Healthcare NHS Foundation Trust (North Tyneside General Hospital and Wansbeck General Hospital), North Shields and Ashington, UK
3 School of Health Sciences, Queen Margaret University, Edinburgh, UK
4 Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK
5 International Centre for Neurorehabilitation, Newcastle upon Tyne, UK
* Corresponding author Email: helen.rodgers@ncl.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document